Chemed Corporation
Chemed Corporation (CHE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CHE · as of Jun 8, 2026
Key Statistics
Explore Chemed Corporation Data
che stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 44.4%
The CHE analyst consensus is Hold, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $475.00, representing +7.57% upside from the current price of $441.59.
Competitors & Peers
che competitorsCHE
ATR
BRKR
BTSG
DVA
HSICStock Performance
Full HistoryAbout Chemed Corporation
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in …
what is chemed corporation · che stock overview · chemed corporation company profile · who is chemed corporation ceo · che NYSE · chemed corporation headquarters · chemed corporation business segments
About Stock Overview & Key Data
Chemed Corporation (CHE) is a Healthcare company in the Medical - Care Facilities industry, listed on NYSE since May 3, 1973. As of the latest trading session, CHE stock price is $441.59, with a market capitalization of $5.9B. The stock has returned -19.72% over the past 12 months and +3.21% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Chemed Corporation stock is Hold, with an average 12-month price target of $475.00. In fiscal year 2025, Chemed Corporation reported revenue of $2.5B and net income of $265.2M. For detailed data — including Chemed Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Chemed Corporation (CHE) stock price is $441.59. The stock is traded on NYSE under the ticker symbol CHE. The 52-week range is $365.21 – $565.66.